期刊
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
卷 389, 期 5, 页码 1397-1407出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00216-007-1500-z
关键词
ICR; FT-ICR; FTMS; O-Glycosylation; electron capture dissociation
资金
- NCRR NIH HHS [RR17261] Funding Source: Medline
- NIDCR NIH HHS [DE13694] Funding Source: Medline
- NIDDK NIH HHS [DK64400, DK61525, DK47322, DK71802, DK78244] Funding Source: Medline
- NIGMS NIH HHS [R01 GM098539] Funding Source: Medline
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis. In IgAN, IgA1 molecules with incompletely galactosylated O-linked glycans in the hinge region (HR) are present in mesangial immunodeposits and in circulating immune complexes. It is not known whether the galactose deficiency in IgA1 proteins occurs randomly or preferentially at specific sites. We have previously demonstrated the first direct localization of multiple O-glycosylation sites on a single IgA1 myeloma protein by use of activated ion-electron capture dissociation (AI-ECD) Fourier transform ion cyclotron resonance (FT-ICR) tandem mass spectrometry. Here, we report the analysis of IgA1 O-glycan heterogeneity by use of FT-ICR MS and liquid chromatography FT-ICR MS to obtain unbiased accurate mass profiles of IgA1 HR glycopeptides from three different IgA1 myeloma proteins. Additionally, we report the first AI-ECD fragmentation on an individual IgA1 O-glycopeptide from an IgA1 HR preparation that is reproducible for each IgA1 myeloma protein. These results suggest that future analysis of IgA1 HR from IgAN patients and normal healthy controls should be feasible.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据